BiotechTube
Home/Regor Therapeutics/Michael Nauck
MN

Michael Nauck

Head of Clinical Research Advisor (Diabetes)

Regor Therapeutics

Therapeutic Areas

OncologyMetabolismImmunology

Regor Therapeutics Pipeline

DrugIndicationPhase
RGT-075ObesityPhase 2b
GDC-4198 (RGT-419B)HR+/HER2- Breast CancerPhase 1
GDC-0587 (RGT-587)HR+/HER2- Breast CancerPhase 1

Leadership Team at Regor Therapeutics

XQ
Xiayang Qiu
Founder and CEO
DB
Domenick Bertelli
Senior Biopharmaceutical Industry Advisor
View full Regor Therapeutics profile